Robert Ossig

1 month ago | pharmaceuticalonline.com | Robert Ossig |Victoria Morgan |David Lyon

Webinar: Pharmaceutical Labeling: How To Optimize Labeling In A Pharmaceutical EnvironmentAccurate and readable pharmaceutical labeling ensures patient safety, effective medication use, and regulatory compliance. In this webinar, you’ll learn how factors like speed, printing methods, and inspection criteria influence the choice of labeling machinery.

Oct 21, 2024 | cellandgene.com | Elben Guimaraes |Robert Ossig |Junwei Sun |Lucia Fernandez |Lucia Fernández

On-Demand Webinar - The Road to Approval: Viral Clearance Strategies for Non-Enveloped Viral VectorsDid you know that the ICH Q5A(R2) guideline is now including the expectation for viral clearance studies for non-enveloped viral vectors? Watch this webinar to get the keys to design a successful study for your AAV products. Each approach has its advantages and drawbacks, making the decision-making process crucial for your organization.

Sep 19, 2024 | bioprocessonline.com | Mike Ulman |Crystal Hostler |Mesa Laboratories |Robert Ossig

PAT: Build Quality into Biopharmaceutical Processes with Real-Time Monitoring and ControlAutomated aseptic sampling is a process analytical technology (PAT) tool that offers significant benefits for bioprocesses, including reduced contamination risk, higher measurement frequency, and improved efficiency compared to standard manual sampling. As a result, it enables improved process understanding and tighter process control. Learn more here.

Sep 10, 2024 | cellandgene.com | Robert Ossig

Article | September 10, 2024 By Robert Ossig The Handover stage of transitioning from technology transfer (TT) to commercial production is a vital phase for biopharmaceutical companies. This stage involves transferring operations from the TT Team to the Receiving Unit (RU), requiring careful coordination across multiple functions.

Aug 12, 2024 | pharmaceuticalonline.com | Robert Ossig

Article | August 12, 2024 By Robert Ossig, Process & Manufacturing Technology Explore the transformative potential of cutting-edge cell and gene therapies, focusing on CAR-T cell therapy, CRISPR-Cas9 gene editing, and other advanced approaches. CAR-T therapy involves engineering patient T cells to target and destroy cancer cells, exemplified by Kymriah for leukemia and lymphoma.